The general interpretation of these results suggests that the serum level of vaspin may independently predict GDM in approximately 40% of women in contrast to nesfatin-1 levels, which may predict only 13% of GDM in the analyzed group of patients. The gene discussed is NUCB2; the disease is gestational diabetes.